Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathway

Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathway

US Patent 9241939 · Granted Jan 26, 2016

Estimated economic value: $5,028,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
Therapeutic combinations comprising a c-RAF inhibitor2024
Method of treating a proliferative disease2021
Therapeutic uses of a C-RAF inhibitor2021
Combination therapy2020
Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhi2019
Combination therapy2018
Pharmaceutical diagnostic2017
Pharmaceutical diagnostic2017
Pharmaceutical combinations of a CDK4/6 inhibitor and a B-RAF inhibitor2017
Synergistic combinations of PI3K- and MEK-inhibitors2017
Pharmaceutical combinations comprising a B-RAF inhibitor, and EGFR inhibitor and2016